179 related articles for article (PubMed ID: 8795578)
1. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients.
Robson H; Anderson E; James RD; Schofield PF
Br J Cancer; 1996 Sep; 74(5):753-8. PubMed ID: 8795578
[TBL] [Abstract][Full Text] [Related]
2. Significance of transforming growth factor beta1 as a new tumor marker for colorectal cancer.
Narai S; Watanabe M; Hasegawa H; Nishibori H; Endo T; Kubota T; Kitajima M
Int J Cancer; 2002 Feb; 97(4):508-11. PubMed ID: 11802214
[TBL] [Abstract][Full Text] [Related]
3. Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas.
Van Laethem JL; Resibois A; Adler M; Peny MO; Ohtani H; Robberecht P
Dig Dis Sci; 1996 Sep; 41(9):1741-8. PubMed ID: 8794788
[TBL] [Abstract][Full Text] [Related]
4. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression.
Tsushima H; Kawata S; Tamura S; Ito N; Shirai Y; Kiso S; Imai Y; Shimomukai H; Nomura Y; Matsuda Y; Matsuzawa Y
Gastroenterology; 1996 Feb; 110(2):375-82. PubMed ID: 8566583
[TBL] [Abstract][Full Text] [Related]
5. Expression and role of thrombospondin-1 in colorectal cancer.
Miyanaga K; Kato Y; Nakamura T; Matsumura M; Amaya H; Horiuchi T; Chiba Y; Tanaka K
Anticancer Res; 2002; 22(6C):3941-8. PubMed ID: 12553016
[TBL] [Abstract][Full Text] [Related]
6. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 in colonic neoplasia: a genetic molecular and immunohistochemical study.
Cardillo MR; Yap E
J Exp Clin Cancer Res; 1997 Sep; 16(3):281-8. PubMed ID: 9387902
[TBL] [Abstract][Full Text] [Related]
10. Differential changes in transforming growth factor-beta isoform expression during postnatal cardiac growth.
Haworth RS; Brooks G; Cummins P; Dobie K; Chilton DC; Avkiran M
Biochem Biophys Res Commun; 1998 Apr; 245(3):923-7. PubMed ID: 9588216
[TBL] [Abstract][Full Text] [Related]
11. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
[TBL] [Abstract][Full Text] [Related]
12. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor beta1 by nitric oxide.
Vodovotz Y; Chesler L; Chong H; Kim SJ; Simpson JT; DeGraff W; Cox GW; Roberts AB; Wink DA; Barcellos-Hoff MH
Cancer Res; 1999 May; 59(9):2142-9. PubMed ID: 10232601
[TBL] [Abstract][Full Text] [Related]
14. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
Cardillo MR; Yap EP
Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
[TBL] [Abstract][Full Text] [Related]
17. Expression of Smad4 and TGF-beta2 in colorectal carcinoma.
Kouvidou Ch; Latoufis C; Lianou E; Kouvatseas G; Kakouri E; Anagnostakis D; Vrettou-Aravani V; Betsi E; Karatapanis S
Anticancer Res; 2006; 26(4B):2901-7. PubMed ID: 16886611
[TBL] [Abstract][Full Text] [Related]
18. Significance of positive and inhibitory regulators in the TGF-β signaling pathway in colorectal cancers.
Coates RF; Gardner JA; Gao Y; Cortright VM; Mitchell JM; Ashikaga T; Skelly J; Yang MX
Hum Pathol; 2017 Aug; 66():34-39. PubMed ID: 28601657
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
[TBL] [Abstract][Full Text] [Related]
20. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
Böttinger EP; Factor VM; Tsang ML; Weatherbee JA; Kopp JB; Qian SW; Wakefield LM; Roberts AB; Thorgeirsson SS; Sporn MB
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5877-82. PubMed ID: 8650186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
